Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Contact Lenses to Slow Myopia Progression in Adults

NCT: NCT07747311 · NOT_YET_RECRUITING

NCT IDNCT07747311
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2030-09-30
SponsorUniversity of California, Berkeley (OTHER)
First posted
Last updated

Brief Summary

Myopia (nearsightedness) can continue to worsen during young adulthood, increasing the risk of sight-threatening eye diseases later in life. Although dual-focus soft contacts (DFSC) lenses have been shown to slow myopia progression in children, their effectiveness in adults is not well understood. This study will compare DFSC lenses with standard single-vision soft contact (SVSC) lenses in myopic young adults aged 18 to 30 years. Participants will be randomly assigned to wear one of the two lens types for 24 months. The study will measure changes in axial length and cycloplegic refractive error to determine whether DFSC lenses slow myopia progression in young adults.

Frequently Asked Questions

What is Contact Lenses to Slow Myopia Progression in Adults?

Contact Lenses to Slow Myopia Progression in Adults is a clinical trial registered under NCT07747311. Current status: NOT_YET_RECRUITING.

What is the status of NCT07747311?

The current status of NCT07747311 (Contact Lenses to Slow Myopia Progression in Adults) is: NOT_YET_RECRUITING.

When did Contact Lenses to Slow Myopia Progression in Adults start?

Contact Lenses to Slow Myopia Progression in Adults started on 2026-09-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.